comparemela.com
  1. Home
  2. Live Updates
  3. Sara Hurvitz - Breaking News

Page 2 - Sara Hurvitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SABCS: Seagen outlines Tukysa s value alongside Roche s ADC in breast cancer But FDA path remains unclear

SABCS: Seagen outlines Tukysa s value alongside Roche s ADC in breast cancer But FDA path remains unclear
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesRoger danseySara hurvitzDaiichi sankyo enhertuRoche herceptinAmerican association for cancer researchFred hutchinson cancer centerAntonio breast cancerFierce pharmaAmerican associationCancer researchDaiichi sankyo

Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancer

Adding agent to T-DM1 resulted in 2-month progression-free survival improvement

United statesSan antonioMike bassettValentina guarneriKate lathropSara hurvitzUt health san antonioMays cancer centerFred hutchinson cancer centerUniversity of padovaSan antonio breast cancer

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioKirsten owensJeff boyleMario camponeClaudine isaacsSara hurvitzVepdegestrant monotherapyExchange commissionPfizer incArvinas incArvinas communicationsAntonio breast cancer symposiumProgressposter sessionLead in trialUpdateposter session

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioClaudine isaacsKirsten owensVepdegestrant monotherapySara hurvitzMario camponeJeff boyleArvinas incArvinas communicationsExchange commissionPfizer incPfizer announce updated vepdegestrantAntonio breast cancerAntonio breast cancer symposiumLead in trial

Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium

Six abstracts have been accepted for presentation, including updated data on vepdegestrant alone and in combination with palbociclib NEW HAVEN, Conn. and NEW YORK, Nov. 28, 2023 .

United statesSan antonioKirsten owensJeff boyleClaudine isaacsVepdegestrant monotherapyMario camponeSara hurvitzExchange commissionPfizer incArvinas incArvinas communicationsAntonio breast cancer symposiumLead in trialPalbociclib phasePharmacodynamic modeling

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.